Clinical Trials Logo

Eczema clinical trials

View clinical trials related to Eczema.

Filter by:

NCT ID: NCT01299610 Completed - Dermatitis, Atopic Clinical Trials

A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

Start date: December 1, 2010
Phase: Phase 2
Study type: Interventional

This study is a randomised, double-blind, placebo-controlled study to assess the efficacy of GW870086X cream formulation in subjects with moderate to severe atopic dermatitis. Subjects will be assigned to take 3 out of the 4 possible treatments for 21 ±2 days: GW870086X 0.2% cream, GW870086X 2% cream, FP 0.05% cream (as a positive control) and placebo cream. All subjects will be randomised to receive placebo cream. Three index lesions located on the arms and/or legs (one on each) will be identified per subject and each treatment will be applied to the same lesion.

NCT ID: NCT01291940 Completed - Atopic Dermatitis Clinical Trials

The Effects of Emollient Therapy on the Skin Barrier

EES
Start date: January 2011
Phase: N/A
Study type: Interventional

The goal of this study is to better understand what effect emollients (moisturizers) have on the skin in young children and adults. Subjects will be recruited from PI and Sub-I clinics and Oregon Health & Science University (OHSU) research opportunities website. 1. Adult and Adolescent Study: Moisturizer Intervention - There will be 2-3 visits for this study: a screening visit, a baseline visit, and a final visit. Adults with a history of eczema will be asked to apply one of four possible moisturizers to one arm and nothing to the other arm for four weeks. The moisturizers, which will be assigned to the subjects, include either Cetaphil Cream, Aveeno Eczema Therapy Moisturizing Cream, CeraVe Moisturizing Cream, or Vaseline 100% Petroleum Jelly. Subjects can use other skin treatments as needed for their skin condition, but may not treat the arms during the study. Non-invasive tests of the skin will be made at Visit 1 and after four weeks (Visit 2). The skin measurements that will be performed are: - Transepidermal loss (TEWL)- measures how much water is lost across the skin barrier - Skin Cohesion and TEWL - TEWL after 5, 10, 15, and 20 tape strips will measure skin barrier function after tape-stripping - Skin electrical capacitance - measures the moisture in the top layer of skin - Skin pH - measures the acidity of the skin - Stratum corneum cohesion assay - tape-stripping to measure the protein removed from the top layer of skin - Lipidomic analysis - measures the lipids, or oils, in the top layer of skin Control - There will be 1-2 visits for this group: a screening visit and baseline visit, which can be combined. Non-invasive tests of the skin will be taken and include the skin measurements that will be performed are the same as the Moisturizer Intervention group. 2. Pediatric Study: There will be 2-3 visits for this study: a screening visit, a baseline visit, and a final visit. Infants and toddlers between 3 months and 3 years of age without a history of skin barrier diseases will be assigned to a moisturizer, which include either Cetaphil Cream, Aveeno Eczema Therapy Moisturizing Cream, CeraVe Moisturizing Cream, or Aveeno Skin Relief Moisture Repair Cream. Non-invasive tests of the skin will be made at Visit 1 and after four weeks (Visit 2). - TEWL- measures how much water is lost across the skin barrier - Skin electrical capacitance - measures the moisture in the top layer of skin - Skin pH - measures the acidity of the skin

NCT ID: NCT01286220 Terminated - Clinical trials for Moderate to Severe Atopic Dermatitis

Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis

Start date: December 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if twice weekly 10 minute dilute bleach baths decreases disease severity in patients with moderate to severe atopic dermatitis.

NCT ID: NCT01259323 Completed - Dermatitis Clinical Trials

Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis

Start date: December 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the Safety and Tolerability of REGN668 (how the body reacts to the drug) compared to placebo (an inert substance) in patients with moderate-to-severe extrinsic Atopic Dermatitis.

NCT ID: NCT01257061 Completed - Eczema Clinical Trials

Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment

Start date: September 6, 2012
Phase: Phase 3
Study type: Interventional

Atopic dermatitis is a recurrent pruritic skin disorder which has a significant morbidity and impaired quality of life due specially pruritus and physical visible skin lesions. The propose of this trial is evaluate the effectiveness of clemastine fumarate 1, 0 mg/g + dexamethasone 0, 5 mg/g compared to dexchlorpheniramine maleate 10 mg/g in eczema treatment.

NCT ID: NCT01254240 Recruiting - Psoriasis Clinical Trials

Efficacy Study of Two Choices of Phototherapy on Itching Skin Diseases

PRUVAB
Start date: December 2010
Phase: Phase 2
Study type: Interventional

This is a double-blind prospective randomized monocenter study comparing the efficacy of two phototherapy ultraviolet spectra on pruritus (itching) of inflammatory skin diseases. 40 patients per treatment, in total 80 study participants.

NCT ID: NCT01246973 Completed - Clinical trials for Radiation-induced Dermatitis

Oral Curcumin for Radiation Dermatitis

Start date: February 2011
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to determine whether curcumin, an ingredient of some foods, can prevent or reduce the severity of skin reactions (dermatitis) caused by radiation therapy. Dermatitis is a common side effect of radiation treatment, but few effective treatments have been developed for it. Curcumin is a natural compound found in both turmeric and curry powder. It has been used for centuries as a spice (curry), a food coloring and as a food preservative. Curcumin is non-toxic and has been found to enhance the functions of normal tissues..

NCT ID: NCT01244607 Completed - Clinical trials for Allergic Contact Dermatitis

NI-0801 in Allergic Contact Dermatitis

Start date: n/a
Phase: Phase 1
Study type: Interventional

The purpose of the study is to assess the effect of a single dose of NI-0801 on the severity of nickel-induced allergic contact dermatitis.

NCT ID: NCT01244230 Completed - Atopic Dermatitis Clinical Trials

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)

Start date: November 2010
Phase: Phase 2/Phase 3
Study type: Interventional

Primary Objective: To evaluate safety (4 weeks) Secondary Objectives: - To evaluate the long-term safety (12 weeks) - To evaluate the efficacy - To characterize the pharmacokinetic profile

NCT ID: NCT01239719 Not yet recruiting - Allergy Clinical Trials

Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis

Start date: March 2011
Phase: Phase 3
Study type: Interventional

The aim of this study is to prove the efficacy of the dexamethasone 0.5 mg + 1 mg clemastine fumarate tablet compared to 0.5 mg of dexamethasone in reducing the signs and symptoms of allergic dermatitis.